Navigation Links
Schering-Plough and Merck Announce Withdrawal of Loratadine/Montelukast NDA and Termination of Respiratory Joint Venture
Date:6/27/2008

KENILWORTH and WHITEHOUSE STATION, N.J., June 27 /PRNewswire-FirstCall/ -- Schering-Plough Corp. (NYSE: SGP) and Merck & Co., Inc. (NYSE: MRK) announce the withdrawal of the New Drug Application (NDA) for the loratadine/montelukast combination tablet.

The companies also terminated the Schering-Plough/Merck Pharmaceuticals respiratory joint venture, which was formed in May 2000 to develop and market a fixed-combination product that would combine loratadine and montelukast. This action has no impact on the business of the Merck/Schering-Plough cholesterol joint venture.

The U.S. Food and Drug Administration (FDA) issued on April 25, 2008 a not-approvable letter for the proposed fixed-dose combination of loratadine and montelukast.

As a result of the termination of the respiratory joint venture, Schering- Plough expects to receive payments totaling $105 million from Merck as specified in the joint venture agreements which Schering-Plough will recognize over the remaining three quarters of 2008.


'/>"/>
SOURCE Schering-Plough Corp.; Merck & Co., Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. Hagens Berman Appointed Co-Lead Counsel in Case Against Schering-Plough and Merck
2. Emerging Combination Therapies, Including Drugs from Novartis/Schering-Plough and GlaxoSmithKline/Theravance Will Drive the COPD Drug Market to More Than $11 Billion in 2017
3. Bayer/Schering-Plough/Shionogis Avelox Has Advantages Over Levofloxacin in the Treatment of Community-Acquired Pneumonia
4. Schering-Plough Announces Expanded Stock Retention Guidelines for Senior Management
5. Schering-Plough to Webcast Presentation by CEO Fred Hassan at Lehman Brothers Eleventh Annual Global Healthcare Conference
6. Schering-Plough Promotes Ian Mcinnes to President of Global Supply Chain
7. CORRECTED: Hagens Berman Sobol Shapiro Files Suit Against Merck and Schering-Plough
8. Lawsuit Filed in Florida Federal Court Over Marketing of Vytorin and Zetia By Merck and Schering-Plough
9. Schering-Plough CEO to Buy $2 Million in Common Shares
10. Schering-Plough Board Elects Dr. Craig B. Thompson as a Director
11. Centocor, Schering-Plough Revise Agreement Covering REMICADE, Golimumab
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... of Steve Pasierb, President ,, NEW YORK, ... Michigan,s Monitoring the Future study (MTF) -- the largest ... 10th and 12th graders -- underscores that teens, intentional ... to be a cause for concern, with an alarming ... friends and relatives. ,, Teen Abuse ...
(Date:12/14/2009)... Dec. 14 When Kurth Krause, an ... instructions for landing on the moon, he,was confident ... anything.,Years later, Kurth realized there was one thing ... kidney transplant and even though dialysis machines,would keep ... a transplant. Kurth,wrote: "My wife is 69 and ...
(Date:12/14/2009)... from the UC San Diego School of Medicine and ... that helps prevent liver damage, including inflammation, fibrosis and ... how the protein, TAK1, works could lead to new ... , "TAK1 appears to be a master regulator ... of medicine and Dean of the UC San Diego ...
(Date:12/14/2009)... cites lower rates for meth and smoking, but ... 14 (HealthDay News) -- Fewer teenagers are using ... and abuse of prescription drugs remains high, U.S. ... that newer drugs, such as the hallucinogenic salvia ... intended for treatment of attention-deficit hyperactivity disorder (ADHD), ...
(Date:12/14/2009)... Concetta F. Conkling of Moraga, CA, retired ... has been elected Chair of the Board of Trustees ... the nearly 90-year-old organization to which Helen Keller devoted ... York with offices in San Francisco, Dallas, ... is dedicated to expanding possibilities for people with vision ...
Breaking Medicine News(10 mins):Health News:Partnership for a Drug-Free America(R) Responds to 2009 Monitoring the Future Study Results 2Health News:Partnership for a Drug-Free America(R) Responds to 2009 Monitoring the Future Study Results 3Health News:69-Year-Old Grandmother Needing A Lifesaving Kidney Transplant Finds a Miracle on the Internet: a 25-Year-Old Living Altruistic Organ Donor Stranger 2Health News:69-Year-Old Grandmother Needing A Lifesaving Kidney Transplant Finds a Miracle on the Internet: a 25-Year-Old Living Altruistic Organ Donor Stranger 3Health News:Scientists uncover protective mechanism against liver cancer 2Health News:Marijuana Use No Longer Dropping Among U.S. Teens 2Health News:Marijuana Use No Longer Dropping Among U.S. Teens 3Health News:Marijuana Use No Longer Dropping Among U.S. Teens 4Health News:The American Foundation for the Blind Welcomes New Board Chair, Concetta F. Conkling 2
... July 8 Southern Home Medical,Equipment, Inc. (OTC: SHOM) ... 63% revenue increase in the second quarter of 2008,compared ... and CEO of,the Company, stated, "We have focused a ... and development of Encore Medical Staffing. We are,very excited ...
... July 8 TransUnion and Benchmark,Revenue Management ... hospitals,to provide better financial avenues to patients ... healthcare revenue cycle,platform and predictive analytics capabilities ... workflow solution set., TransUnion,s healthcare revenue ...
... contract, WELLINGTON, Fla., July 8 The ... has announced that Renaissance Health,Systems, a Quantum subsidiary ... Florida, with a new statewide payer (health plan) ... county by county,basis. This new contract encompasses all ...
... /PRNewswire-FirstCall/ - Nuvo Research Inc.,(TSX: NRI), a ... research and,development of drug products delivered to ... transdermal drug delivery technologies, and Paladin Labs ... company, today,announced modifications to their existing licensing ...
... Patient Data System, CAMBRIDGE, England and SAN ... or AU.L), a global leader in,infrastructure software for ... (SES), a provider of public healthcare services to ... Spain, has selected,Autonomy,s Meaning-based Computing solution to quickly ...
... Income History; Allsup Answers Common Benefits Questions , ... ... with a mental or physical disability face many hardships, not the ... no longer can work. While everything about a person’s life changes, ...
Other Medicine News:Health News:Southern Home Medical Reports Its Encore Medical Staffing Division Increases Revenues by 63% 2Health News:TransUnion and Benchmark Revenue Management Partner to Deliver Comprehensive Revenue Cycle Offering 2Health News:TransUnion and Benchmark Revenue Management Partner to Deliver Comprehensive Revenue Cycle Offering 3Health News:TransUnion and Benchmark Revenue Management Partner to Deliver Comprehensive Revenue Cycle Offering 4Health News:The Quantum Group Expands Payer Partnerships 2Health News:The Quantum Group Expands Payer Partnerships 3Health News:Nuvo Research and Paladin announce amendments to Pennsaid and Pennsaid Plus agreements 2Health News:Nuvo Research and Paladin announce amendments to Pennsaid and Pennsaid Plus agreements 3Health News:Spanish Health Service Provider Selects Autonomy to Deliver Innovation Within Healthcare 2Health News:Spanish Health Service Provider Selects Autonomy to Deliver Innovation Within Healthcare 3Health News:Past Earnings Play Role in Determining SSDI Benefits 2Health News:Past Earnings Play Role in Determining SSDI Benefits 3Health News:Past Earnings Play Role in Determining SSDI Benefits 4Health News:Past Earnings Play Role in Determining SSDI Benefits 5
(Date:12/14/2009)... Health today announced that executives of the company will ... Goldman Sachs CEO Unplugged Conference on Jan. 6 ... in New York. 28th Annual J.P. Morgan ... at the Westin St. Francis Hotel in San Francisco. ... Cardinal Health,s diverse products and services, company performance and ...
(Date:12/14/2009)... 14 Southridge LLC ("Southridge"), an ... companies, is pleased to announce that its affiliated fund ... to $15 million in equity financing to Imaging Diagnostic ... years of financing the growth of Imaging Diagnostic Systems, ... produce new developments in the field of early breast ...
(Date:12/14/2009)... 14 At GeoInvesting.com, we have been tracking ... time now. Our largest hang up had been with ... fiscal June 2010 net income guidance of $11.3 million ... net income of $7.9 million, the increase in shares ... scenario, which depends upon the share price and the ...
Breaking Medicine Technology:Cardinal Health Executives to Speak at Two Investor Events in January 2Southridge LLC Provides Funding Through Private Equity Agreement with Imaging Diagnostic Systems, Inc. 2GeoInvesting.com Offers Insight Into Two Growing Chinese Pharmaceutical Firms 2Wyeth Announces Holder Right to Surrender Convertible Debentures 12653 1Wyeth Announces Holder Right to Surrender Convertible Debentures 12653 2Wyeth Announces Holder Right to Surrender Convertible Debentures 12653 3Wyeth Announces Holder Right to Surrender Convertible Debentures 12653 4Data Presented at Society of Nuclear Medicine 2009 Annual Meeting Supports Potential of Peregrines Cotara 28R 29 for the Treatment of Brain Cancer 12651 1Data Presented at Society of Nuclear Medicine 2009 Annual Meeting Supports Potential of Peregrines Cotara 28R 29 for the Treatment of Brain Cancer 12651 2Data Presented at Society of Nuclear Medicine 2009 Annual Meeting Supports Potential of Peregrines Cotara 28R 29 for the Treatment of Brain Cancer 12651 3Data Presented at Society of Nuclear Medicine 2009 Annual Meeting Supports Potential of Peregrines Cotara 28R 29 for the Treatment of Brain Cancer 12651 4Data Presented at Society of Nuclear Medicine 2009 Annual Meeting Supports Potential of Peregrines Cotara 28R 29 for the Treatment of Brain Cancer 12651 5Data Presented at Society of Nuclear Medicine 2009 Annual Meeting Supports Potential of Peregrines Cotara 28R 29 for the Treatment of Brain Cancer 12651 6Torn Surgical Gloves Put Patients at Risk for Infection 49069 1Torn Surgical Gloves Put Patients at Risk for Infection 49069 2
... Primary and Secondary Endpoints Do Not Achieve Statistical Significance ... Affirms Plans to File NGX-4010 NDA in 2008 ... Call at 5:00 p.m. EST, SAN MATEO, Calif., Feb. ... focused on developing and,commercializing novel pain management therapies, today announced,preliminary ...
... Feb. 26 Pharmacopeia,(Nasdaq: PCOP ), an ... molecule therapeutics, today announced the completion of recruitment,in ... PS433540 (DARA),the company,s lead internal product candidate. The ... study is to,evaluate the efficacy and safety of ...
Other Medicine Technology:NeurogesX Announces Preliminary Results from Second Phase 3 Clinical Trial in HIV-DSP 2NeurogesX Announces Preliminary Results from Second Phase 3 Clinical Trial in HIV-DSP 3NeurogesX Announces Preliminary Results from Second Phase 3 Clinical Trial in HIV-DSP 4NeurogesX Announces Preliminary Results from Second Phase 3 Clinical Trial in HIV-DSP 5NeurogesX Announces Preliminary Results from Second Phase 3 Clinical Trial in HIV-DSP 6NeurogesX Announces Preliminary Results from Second Phase 3 Clinical Trial in HIV-DSP 7Pharmacopeia Completes Enrollment in Phase 2 Hypertension Study with PS433540 (DARA) 2Pharmacopeia Completes Enrollment in Phase 2 Hypertension Study with PS433540 (DARA) 3Pharmacopeia Completes Enrollment in Phase 2 Hypertension Study with PS433540 (DARA) 4
Designed for larger laboratories or research applications, the Concept 1000 boasts some very unique features....
... The world's smallest anaerobic ... of the larger Ruskinn Concept ... to improve isolation rates and ... alternative to anaerobic jars. Bugbox ...
... supply, MERKUR offers a broad range of applications. ... for ease of operation. For the height adjustment, ... hydraulic system. Thanks to its uncomplicated handling, MERKUR ... highly mobile and flexible manner. Furthermore, a comprehensive ...
... With MARS, the operating theatre is ready ... specialist surgical fields. Its modern design allows a ... tasks. The individual components are connected securely and ... coupling system. And if there should ever be ...
Medicine Products: